Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toru Yamano is active.

Publication


Featured researches published by Toru Yamano.


Tetrahedron Letters | 1999

Enantioselective hydrogenation of β-keto esters catalyzed by P-chiral bis(dialkylphosphino)ethanes-Ru(II)

Toru Yamano; Naohiro Taya; Mitsuru Kawada; Taisheng Huang; Tsuneo Imamoto

Abstract Asymmetric hydrogenation of keto esters using a BisP ∗ RuBr 2 catalyst is reported. High enantioselectivities up to 98% were achieved in the hydrogenation of β-keto esters.


Tetrahedron-asymmetry | 2003

Practical synthesis of (R)-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid: a key intermediate for a therapeutic drug for neurodegenerative diseases

Tatsuya Ito; Tomomi Ikemoto; Toru Yamano; Yukio Mizuno; Kiminori Tomimatsu

Abstract A practical method for the preparation of ( R )-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid ( R )- 2 , a key intermediate for a therapeutic drug for neurodegenerative diseases, has been developed. rac -Methyl 6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-(propionyloxy)phenyl) hexanoate rac - 9b was synthesized from 2-methylnaphthoquinone in seven steps. An optically active ester ( R )- 9b was readily obtained from the corresponding racemic ester by lipase-catalyzed resolution, followed by sulfation or phosphorylation. Sulfation by a sulfur trioxide pyridine complex or phosphorylation by phosphoryl chloride enabled facile isolation of the optically active ester simply by extraction. Optically active acid ( R )- 2 was synthesized in excellent enantiomeric excess by hydrolysis of ( R )- 9b followed by recrystallization. The present synthesis of ( R )- 2 was accomplished in 10 steps without requiring chromatographic purification.


Bioorganic & Medicinal Chemistry Letters | 2011

Design, synthesis, and structure-activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors.

Tohru Yamashita; Makoto Kamata; Satoshi Endo; Mitsuo Yamamoto; Keiko Kakegawa; Hiroyuki Watanabe; Katsuhiko Miwa; Toru Yamano; Masaaki Funata; Jyunichi Sakamoto; Akiyoshi Tani; Clifford D. Mol; Hua Zou; Douglas R. Dougan; Bi-Ching Sang; Gyorgy Snell; Kohji Fukatsu

The co-crystal structure of the human acetyl-coenzyme A 2 (ACC2) carboxyl transferase domain and the reported compound CP-640186 (1b) suggested that two carbonyl groups are essential for potent ACC2 inhibition. By focusing on enhancing the interactions between the two carbonyl groups and the amino acid residues Gly(2162) and Glu(2230), we used ligand- and structure-based drug design to discover spirolactones bearing a 2-ureidobenzothiophene moiety.


Heterocycles | 1993

Synthesis of a key intermediate for D-biotin via 1,3-cycloaddition of a thiocarbonyl ylide and sila-Pummerer rearrangement

Toru Yamano; Mitsutaka Tanaka; Kunio Takanohashi

An efficient preparation of a d-biotin intermediate, (±)-(3aα,4α,6aα)-1,3-dibenzyl-3a,4,6,6a-tetrahydro-4-hydroxy-1H-thieno[3,4-d]imidazol-2(3H)-one was accomplished by use of 1,3-cycloaddition of a thiocarbonyl ylide, Curtius rearrangement and sila-Pummerer rearrangement. Addition of p-toluenesulfonic acid was found to be effective to promote sila-Pummerer rearrangement of sterically unfavorable anti-2-trimethylsilyl sulfoxide


Organic Letters | 2002

Highly enantioselective reformatsky reaction of ketones: chelation-assisted enantioface discrimination.

Akio Ojida; Toru Yamano; Naohiro Taya; Akihiro Tasaka


Journal of Medicinal Chemistry | 2002

Synthesis of a Novel Series of Benzocycloalkene Derivatives as Melatonin Receptor Agonists

Kohji Fukatsu; Osamu Uchikawa; Mitsuru Kawada; Toru Yamano; Masayuki Yamashita; Koki Kato; Keisuke Hirai; Shuji Hinuma; Masaomi Miyamoto; Shigenori Ohkawa


Tetrahedron-asymmetry | 2006

Approach to the stereoselective synthesis of melatonin receptor agonist Ramelteon via asymmetric hydrogenation

Toru Yamano; Masayuki Yamashita; Mari Adachi; Mitsutaka Tanaka; Kiyoharu Matsumoto; Mitsuru Kawada; Osamu Uchikawa; Kohji Fukatsu; Shigenori Ohkawa


Chemical & Pharmaceutical Bulletin | 2006

Optically Active Cyclohexene Derivative as a New Antisepsis Agent: An Efficient Synthesis of Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242)

Masami Yamada; Takashi Ichikawa; Toru Yamano; Fumio Kikumoto; Yuji Nishikimi; Norikazu Tamura; Tomoyuki Kitazaki


Chemistry Letters | 2000

A Practical Method for Optical Resolution of Racemic Alcohols or Esters via Lipase-Catalyzed Transformation and Sulfation

Toru Yamano; Fumio Kikumoto; Shozo Yamamoto; Katsuhiko Miwa; Mitsuru Kawada; Tatsuya Ito; Tomomi Ikemoto; Kiminori Tomimatsu; Yukio Mizuno


Archive | 2000

Process for producing optically active naphthalene derivative and optical resolver therefor

Isao Aoki; Mari Adachi; Mitsuru Kawada; Toru Yamano; Naohiro Taya

Collaboration


Dive into the Toru Yamano's collaboration.

Top Co-Authors

Avatar

Kunio Takanohashi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mitsutaka Tanaka

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Masayuki Yamashita

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mitsuru Kawada

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Naohiro Taya

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Isao Aoki

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Mari Adachi

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Haruomi Honda

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kazuo Nakahama

Takeda Pharmaceutical Company

View shared research outputs
Top Co-Authors

Avatar

Kohji Fukatsu

Takeda Pharmaceutical Company

View shared research outputs
Researchain Logo
Decentralizing Knowledge